Goldman Sachs’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.4M Buy
+5,391,772
New +$113M 0.01% 1186

Other funds holding ATTO

Goldman Sachs's ATTO Position: Q3 2026 in Review

Goldman Sachs opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 5,391,772 shares worth $92.4M. The stake represents 0.01% of the portfolio and ranks #1186 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Goldman Sachs held 5,391,772 shares of Attovia Therapeutics worth $92.4M as of Q3 2026.
  • Attovia Therapeutics was a new Goldman Sachs position in Q3 2026.
  • Attovia Therapeutics made up 0.01% of Goldman Sachs's portfolio in Q3 2026, its #1186 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.